COVID vaccine from Germany’s CureVac just 48% effective

Indonesia holds mass vaccination to scale up virus fight
1 July 2021
Patients paying for unproven IVF add-on treatments
1 July 2021

COVID vaccine from Germany’s CureVac just 48% effective

Germany’s CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna.

Comments are closed.